Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.

por Venesmaa, P., Lehtovirta, P., Stenman, U. H., Leminen, A., Forss, M., Ylikorkala, O.
Publicado 1994

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma

por Lassus, H, Sihto, H, Leminen, A, Nordling, S, Joensuu, H, Nupponen, N N, Butzow, R
Publicado 2004

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation

por Paju, A, Sorsa, T, Tervahartiala, T, Koivunen, E, Haglund, C, Leminen, A, Wahlström, T, Salo, T, Stenman, U-H
Publicado 2001

Prognostic role of CIP2A expression in serous ovarian cancer

por Böckelman, C, Lassus, H, Hemmes, A, Leminen, A, Westermarck, J, Haglund, C, Bützow, R, Ristimäki, A
Publicado 2011